Quiz Time
A nurse working in the intensive care unit administers 100 mg of diazepam I.V. as ordered by the new resident. Although she checks on…
Technology
FDA approves new implantable hearing device
On March 20, the U.S. Food and Drug Administration (FDA) approved the first implantable device for people 18 and older with severe or profound…
FDA allows marketing of first device to prevent migraine headaches
On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This…
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
FDA approves Omontys for anemia in dialysis patients
On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease…
FDA approves Imbruvica to treat chronic lymphocytic leukemia
On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have…
Study: Radiation therapy skin reactions may be preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of…
A partnership to enhance outcomes through quality dashboards and action
Learn how a multidepartmental task force improved a hospital’s data display and action-planning tools
FDA approves marketing of postnatal test for developmental disabilities
On Jan. 17, the U.S. Food and Drug Administration (FDA) announce that it has authorized for marketing the Affymetrix CytoScan Dx Assay, which can…
The disappearing inpatient
As hospital admissions shrink, nursing jobs are shiftingto other areas, such as outpatient offices, clinics, postacute facilities, and home care.
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts that form…
FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in…
Quiz Time
A nurse working in the intensive care unit administers 100 mg of diazepam I.V. as ordered by the new resident. Although she…
FDA approves new implantable hearing device
On March 20, the U.S. Food and Drug Administration (FDA) approved the first implantable device for people 18 and older with severe…
FDA allows marketing of first device to prevent migraine headaches
On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine…
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
FDA approves Omontys for anemia in dialysis patients
On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic…
FDA approves Imbruvica to treat chronic lymphocytic leukemia
On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients…
Study: Radiation therapy skin reactions may be preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first…
A partnership to enhance outcomes through quality dashboards and action
Learn how a multidepartmental task force improved a hospital’s data display and action-planning tools
FDA approves marketing of postnatal test for developmental disabilities
On Jan. 17, the U.S. Food and Drug Administration (FDA) announce that it has authorized for marketing the Affymetrix CytoScan Dx Assay,…
The disappearing inpatient
As hospital admissions shrink, nursing jobs are shiftingto other areas, such as outpatient offices, clinics, postacute facilities, and home care.
FDA approves new stent for treatment of pseudocysts of the pancreas
On Dec. 18, the U.S. Food and Drug Administration (FDA) allowed marketing of the AXIOS Stent and Delivery System for treating pseudocysts…
FDA approves new treatment for genetic coagulation disorder
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.